Irritable bowel syndrome. Irritable bowel syndrome
Conditions
Interventions
Intervention group: intervention group receives one 100 mg tablet per 8 hours which is the combination of three plants
Intervention 1: Intervention group: intervention group receives one 100 mg tablet per 8 hours which is the combination of three plants
Achillea millefolium, Shirazi Matricaria chamomilla and Glycyrrhiza glabra ( The tablets are produced by Goldaru Company and are available in the market ). The intervention period duration is 15 days.
Treatment - Drugs
Control group: control group receives placebo 100 mg tablets that are like drug tablets for every 8 hours which is without effective material. The placebo is made by pharmacologist of the Tohid Medica
Sponsors
Vice Chancellor for research of Kurdistan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 90 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria: Patients with irritable bowel syndrome diagnostic according to ROM III Criteria; Age 15-90 years; living in Sananadaj Exclusion Criteria: Patients who had undergone abdominal surgery or other abdominal diseases; patients who are not willing to discontinue current medications; medical complications; coagulation problems
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Abdominal Pain. Timepoint: Beginning of the study, 2weeks later, Four weeks later. Method of measurement: Mild , Moderate, Sever. | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in excretion pattern. Timepoint: Zero, 2 weeks after intervention, four weeks after initiation of treatment. Method of measurement: clinical history as constipation, diarrhea and normal. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKhaled Minooi
Faculty of Medicine,Kurdistan university of Medical Sciences
Outcome results
None listed